日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer

新辅助雄激素剥夺疗法后免疫反应的时间动态变化提示前列腺癌存在免疫检查点抑制剂治疗的“机会窗口”。

期刊:
影响因子:
doi:10.64898/2026.01.10.26343859
Jamroze, Anmbreen; Zhang, Renyuan; Ahuja, Kriti; Deng, Lei; Jatwani, Karan; Nguyen, Uyen; Farmer, Bailey; James, Gaybrielle; Mastri, Michalis; Eng, Kevin H; Xu, Bo; Saenger, Yvonne M; Yang, Yuanquan; Krolewski, John J; Tang, Dean G; Chatta, Gurkamal; Nastiuk, Kent L
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

恩扎卢胺联合维奈托克治疗转移性去势抵抗性前列腺癌患者的Ib期研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-025-04840-2
Perimbeti, Stuthi; Jamroze, Anmbreen; Gopalakrishnan, Dharmesh; Jain, Rohit; Jiang, Changchuan; Holleran, Julianne L; Parise, Robert A; Bies, Robert; Quinn, David; Attwood, Kristopher; Liu, Xiaozhuo; Green, Kelly; Kirk, Jason S; Beumer, Jan H; Tang, Dean G; Chatta, Gurkamal
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival

干细胞特性增强会促进前列腺癌的进展、可塑性、治疗耐药性和患者生存率降低。

期刊:
影响因子:
doi:10.1101/2025.04.27.650697
Liu, Xiaozhuo; Cortes, Eduardo; Ji, Yibing; Zhao, Kathy; Ho, Julian; Liu, Yang Seagle; Davicioni, Elai; Feng, Felix Y; Alumkal, Joshi J; Spratt, Daniel E; Sweeney, Christopher J; Yu, Han; Hu, Qiang; Cheng, Zou; Zhang, Dingxiao; Chatta, Gurkamal; Nastiuk, Kent L; Goodrich, David W; Rycaj, Kiera; Jamroze, Anmbreen; Kirk, Jason S; Puzanov, Igor; Liu, Song; Wang, Jianmin; Tang, Dean G
肿瘤
肿瘤免疫
细胞生物学
治疗耐药
干细胞
发育与干细胞
前列腺癌
发表日期：2025
文献求助 收藏

Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes

细胞分辨高维成像分析、治疗模型构建以及 Ib 期临床研究证实 BCL-2 是异质性 CRPC 亚型的治疗靶点。

期刊:
影响因子:
doi:10.1101/2025.07.08.663739
Jamroze, Anmbreen; Liu, Xiaozhuo; Hou, Surui; Li, Wen Jess; Yu, Han; Tracz, Amanda; Li, Qiuhui; Nastiuk, Kent; Chen, Xin; Huang, Jiaoti; Lin, Kevin; Lu, Yue; Puzanov, Igor; Kirk, Jason S; Chatta, Gurkamal; Tang, Dean G
细胞生物学
CRP
发表日期：2025
文献求助 收藏

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer.

恩扎卢胺联合维奈托克治疗转移性去势抵抗性前列腺癌患者的 Ib 期研究

期刊:
影响因子:
doi:10.1101/2025.04.22.25326208
Perimbeti Stuthi, Jamroze Anmbreen, Gopalakrishnan Dharmesh, Jain Rohit, Jiang Changchuan, Holleran Julianne L, Parise Robert A, Bies Robert, Quinn David, Attwood Kristopher, Liu Xiaozhuo, Kirk Jason S, Beumer Jan H, Tang Dean G, Chatta Gurkamal
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

整合的单细胞分析揭示了去势抵抗性前列腺腔细胞的表观遗传基础

期刊:Cell Stem Cell
影响因子:19.8
doi:10.1016/j.stem.2024.05.008
Jason S Kirk ，Jie Wang ，Mark Long ，Spencer Rosario ，Amanda Tracz ，Yibing Ji ，Rahul Kumar ，Xiaozhuo Liu ，Anmbreen Jamroze ，Prashant K Singh ，Igor Puzanov ，Gurkamal Chatta ，Qing Cheng ，Jiaoti Huang ，Jeffrey L Wrana ，Jonathan Lovell ，Han Yu ，Song Liu ，Michael M Shen ，Tao Liu ，Dean G Tang
单细胞
表观遗传
细胞生物学
发表日期：2024
文献求助 收藏

Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity

脂质体复合物制剂的mRNA癌症疫苗可诱导强烈的肿瘤新抗原特异性T细胞反应和抗肿瘤活性。

期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.adn9961
Ting Fan ，Congcong Xu ，Jichuan Wu ，Yihua Cai ，Wanlu Cao ，Haifa Shen ，Mingna Zhang ，Hanfei Zhu ，Jingxian Yang ，Zhounan Zhu ，Xiaopin Ma ，Jiale Ren ，Lei Huang ，Qianyun Li ，Yuying Tang ，Bo Yu ，Chunxiu Chen ，Mingcheng Xu ，Qiuhe Wang ，Zhuya Xu ，Fengjia Chen ，Shujing Liang ，Zhixian Zhong ，Anmbreen Jamroze ，Dean G Tang ，Hangwen Li ，Chunyan Dong
免疫/内分泌
T细胞
肿瘤免疫
细胞生物学
肿瘤
T细胞
发表日期：2024
文献求助 收藏

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis

组织因子通路抑制剂-2 (TFPI-2)——癌症和转移中被低估的参与者

期刊:Cancer and Metastasis Reviews
影响因子:8.7
doi:10.1007/s10555-024-10205-7
Wojtukiewicz, Marek Z; Mysliwiec, Marta; Tokajuk, Anna; Kruszewska, Joanna; Politynska, Barbara; Jamroze, Anmbreen; Wojtukiewicz, Anna M; Tang, Dean G; Honn, Kenneth V
信号转导
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer

临床和口服相容性制剂生产的靶向DDX5 (p68) 的分子胶FL118产品，对人类癌症表现出低毒性和高疗效。

期刊:
影响因子:
doi:10.1016/j.jpha.2024.101001
Ling, Xiang; Wu, Wenjie; Yan, Li; Curtin, Leslie; Farrauto, Melanie M; Sexton, Sandra; Jamroze, Anmbreen; Yu, Changjun; Fountzilas, Christos; Tang, Dean G; Li, Fengzhi
DDX5
肿瘤
毒理研究
肿瘤免疫
发表日期：2024
文献求助 收藏

Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence

DEAD-box RNA解旋酶DDX5 (p68)在癌症DNA修复、免疫抑制、癌症代谢调控、病毒感染促进以及对人类微生物组（菌群）的负面影响中的作用

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-023-02787-x
Li, Fengzhi; Ling, Xiang; Chakraborty, Sayan; Fountzilas, Christos; Wang, Jianmin; Jamroze, Anmbreen; Liu, Xiaozhuo; Kalinski, Pawel; Tang, Dean G
肿瘤
肿瘤免疫
炎症/感染
信号转导
代谢
微生物学
DDX5
免疫/内分泌
发表日期：2023
文献求助 收藏